Tesofensine
48 Weeks, Study to Evaluate Overall Safety and Tolerability of Co-administration of Tesofensine and Metoprolol in Subjects With Hypothalamic Injury-induced Obesity (HIO)
NeuroSearch · Phase 2 · Completed · Enrollment 21
| Arm | Population | Dose | Weeks | Estimand | Weight change |
|---|---|---|---|---|---|
| active arm | Obesity or overweight | n/r | 48 | n/r | n/r |
| placebo arm | Obesity or overweight | n/r | 48 | n/r | n/r |